// App-Quantinova.ai

377 : Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)

Researchers

Presenter

  • J. Tolar

Principal Investigators

  • J. McGrath

  • M. Osborn

  • D. Keene

  • M. Riddle

  • K. Hook

  • M. Hordinsky

  • M. Marinkovich

  • D. Woodley

  • M. Chen

  • R. Tryon

  • T. DeFor

  • C. Ebens

  • K. Tamai

  • A. Hovnanian

  • B. Blazar

  • J. Wagner

Medical Centers

  • Osaka U, Osaka, Japan

  • RDEB SCC Sequencing Consortium, Paris, France

  • UMN, Mpls, MN

  • Shriners Hospitals for Children, Portland, OR

  • Univ So CA, Los Angeles, CA

  • RDEB SCC Sequencing Consortium, London, United Kingdom

  • Stanford University School of Medicine, Stanford

Locations

  • Japan

  • France

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Genetic Disorder

Disease

  • Epidermolysis bullosa

  • Epidermolysis bullosa dystrophica, autosomal recessive

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved